论文部分内容阅读
目的:探讨慢性心力衰竭患者采用左西孟旦治疗的效果。方法:选取2015年11月至2016年8月在广东同江医院接受治疗的68例慢性心力衰竭患者,将68例患者随机均分成观察组和对照组,观察组患者在常规药物治疗下采用左西孟旦进行输液治疗,对照组只采用常规药物治疗,分析对比两组的治疗效果。结果:观察组治疗显著率74%高于对照组治疗显著率53%,观察组治疗总有效率100%比对照组总有效率88%高。两组对比差异显著,有统计学意义(P<0.05)。结论:左西孟旦有效改善慢性心力衰竭患者心功能状态,能恢复慢性心力衰竭患者心功能正常级数。
Objective: To investigate the effect of levosimendan treatment in patients with chronic heart failure. Methods: A total of 68 patients with chronic heart failure treated in Guangdong Tongjiang Hospital from November 2015 to August 2016 were randomly divided into observation group and control group. The patients in observation group were treated with conventional medication Ximengdan infusion treatment, the control group only conventional drug treatment, analysis and comparison of the two groups of treatment. Results: The significant rate of treatment in observation group was significantly higher than that in control group (74%). The total effective rate in observation group was 100% higher than that in control group (88%). The difference between the two groups was significant, with statistical significance (P <0.05). Conclusion: Levosimendan can effectively improve the cardiac function in patients with chronic heart failure and restore the normal cardiac function in patients with chronic heart failure.